Retinal vascular occlusions

IU Scott, PA Campochiaro, NJ Newman, V Biousse - The Lancet, 2020 - thelancet.com
Acute retinal vascular occlusions are common causes of visual impairment. Although both
retinal artery occlusions and retinal vein occlusions are associated with increased age and …

Risk factors and treatment strategy for retinal vascular occlusive diseases

R Terao, R Fujino, T Ahmed - Journal of clinical medicine, 2022 - mdpi.com
Retinal occlusive diseases are common diseases that can lead to visual impairment. Retinal
artery occlusion and retinal vein occlusion are included in the clinical entity, but they have …

Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA)

U Schmidt-Erfurth, J Garcia-Arumi, BS Gerendas… - …, 2019 - karger.com
The high prevalence of cardiovascular disease particularly in the elderly population is
associated with retinal vascular disease. Retinal vein occlusions represent severe …

Cardiovascular adverse events with intravitreal anti–vascular endothelial growth factor drugs: a systematic review and meta-analysis of randomized clinical trials

NN Ntjam, M Thulliez, G Paintaud, F Salvo… - JAMA …, 2021 - jamanetwork.com
Importance Systemic safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF)
is a matter of debate and regular updates are necessary. Objective To evaluate systemic …

Intravitreal dexamethasone implant as a sustained release drug delivery device for the treatment of ocular diseases: a comprehensive review of the literature

C Iovino, R Mastropasqua, M Lupidi, D Bacherini… - Pharmaceutics, 2020 - mdpi.com
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical
industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the …

A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion

JL Ang, S Ah-Moye, LN Kim, V Nguyen, A Hunt… - Eye, 2020 - nature.com
This review assessed the real-world evidence of the management of macular oedema
secondary to branch retinal vein occlusion (BRVO). A meta-analysis of 2530 eyes from 48 …

Real-world data: ranibizumab treatment for retinal vein occlusion in the OCEAN study

J Callizo, F Ziemssen, T Bertelmann… - Clinical …, 2019 - Taylor & Francis
Purpose The non-interventional OCEAN study (NCT02194803) evaluated frequency and
monitoring of ranibizumab injections for retinal vein occlusion (RVO) in routine practice in …

Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion

Z Shalchi, O Mahroo, C Bunce… - Cochrane Database of …, 2020 - cochranelibrary.com
Background Branch retinal vein occlusion (BRVO) is one of the most commonly occurring
retinal vascular abnormalities. The most common cause of visual loss in people with BRVO …

Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study

I Pearce, A Clemens, MH Brent, L Lu… - PLoS …, 2020 - journals.plos.org
Objective To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5
mg in treatment-naïve patients with branch retinal vein occlusion (BRVO) enrolled in the …

The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta …

L Xiaodong, X Xuejun - Journal of Ophthalmology, 2022 - Wiley Online Library
Purpose. The purpose of this meta‐analysis was to evaluate the efficacy and safety of
dexamethasone intravitreal implant (DEX) for the treatment of diabetic macular edema …